VEGFA and pulmonary arterial hypertension: Experimental data from SU5496 rodent models suggest that angio-obliterative PAH is likely triggered by an initial pharmacological or endogenous apoptotic agent combined with an additional factor promoting an apoptotic-resistant, hyperproliferative process by increasing VEGF circulating levels [50,89].